TransMedics Group, Inc. - stock earnings

TMDX Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
April 30, 2024 AfterMarket 0.35 / -0.05 - 96.9 million / 85.5 million -

TMDX Quarterly earnings

DateEarningsRevenue
2023Q4 4.0 million USD 81.2 million USD
2023Q3 -25.4 million USD 66.4 million USD
2023Q2 -1.0 million USD 52.5 million USD
2023Q1 -2.6 million USD 41.6 million USD
2022Q4 -6.7 million USD 31.4 million USD
2022Q3 -7.4 million USD 25.7 million USD
2022Q2 -11.5 million USD 20.5 million USD
2022Q1 -10.6 million USD 15.9 million USD
2021Q4 -12.7 million USD 9.7 million USD
2021Q3 -13.0 million USD 5.4 million USD
2021Q2 -10.7 million USD 8.2 million USD
2021Q1 -7.9 million USD 7.1 million USD
2020Q4 -6.3 million USD 7.6 million USD
2020Q3 -5.1 million USD 7.1 million USD
2020Q2 -8.5 million USD 3.4 million USD
2020Q1 -8.9 million USD 7.5 million USD
2019Q4 -9.2 million USD 6.1 million USD
2019Q3 -8.3 million USD 7.2 million USD
2019Q2 -9.2 million USD 5.7 million USD
2019Q1 -6.9 million USD 4.7 million USD
2018Q4 -7.6 million USD 3.5 million USD
2018Q3 -5.1 million USD 4.0 million USD
2018Q2 -6.1 million USD 2.9 million USD
2018Q1 -4.9 million USD 2.5 million USD

TMDX Yearly earnings

DateEarningsRevenue
2023 -25.0 million USD 241.6 million USD
2022 -36.2 million USD 93.5 million USD
2021 -44.2 million USD 30.3 million USD
2020 -28.7 million USD 25.6 million USD
2019 -33.5 million USD 23.6 million USD
2018 -23.8 million USD 13.0 million USD
2017 -20.8 million USD 7.7 million USD
2016 -24.1 million USD 6.2 million USD
2006 -17.6 million USD ? USD

TMDX

Price: $94.13

52 week price:
36.42
99.63

Earnings Per Share: -0.77 USD

P/E Ratio: -79.52

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Volume: 513900

Market Capitalization: 3.1 billion

Links: